Cadila Healthcare Limited has informed the Exchange that CRISIL has, after due consideration, reaffirmed the P1+" (pronounced "P one plus") rating for the 1,250 million Short Term Debt Programme of the Company. This indicates that the degree of safety with regard to timely payment of interest and principal on the instrument is very strong.
| NIFTY 
